Previous 10 |
NEW YORK, Feb. 08, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Twenty-First Century Fox, Inc. (NASDAQ:FOX), Royal Gold, Inc. (NASDAQ:RGL...
PerkinElmer, Inc. (PKI) Q4 2018 Earnings Conference Call January 31, 2019 05:00 PM ET Company Participants Tommy Thomas - Vice President of Investor Relations Robert Friel - Chairman and Chief Executive Officer Prahlad Singh - President and Chief Operating Officer Jamey Mock - ...
PerkinElmer (NYSE: PKI ) Q4 results ($M): Revenue: 756.3 (+17.9%). More news on: PerkinElmer, Inc., Healthcare stocks news, Earnings news and commentary, Read more ...
PerkinElmer (NYSE: PKI ): Q4 Non-GAAP EPS of $1.18 beats by $0.02 ; GAAP EPS of $0.64 misses by $0.27 . More news on: PerkinElmer, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Fourth Quarter 2018 GAAP revenue growth of 18% to $756.3 million; Core organic revenue growth of 7% Fourth Quarter 2018 GAAP earnings per share from continuing operations of $0.64; Adjusted earnings per share of $1.18 Receives CE-IVD Mark for Vanadis NIPT Initiates FY19 ...
PerkinElmer (NYSE: PKI ) is scheduled to announce Q4 earnings results on Thursday, January 31st, after market close. More news on: PerkinElmer, Inc., Earnings news and commentary, , Healthcare stocks news, Read more ...
AFL , AJG , AMZN , CLS , CPT , CY , DECK , EMN , ENVA , EPAY , ESL , EW , EXPO , FBHS , KLIC , LPLA , MATW , MCK , MTX , NFG , OTEX , PFPT , PKI , POST , SIGI , SKYW , SYMC , WAIR , YUMC For Seeking Alpha's full earnings season calendar, click here . More...
The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on January 24, 2019. This dividend is payable on May 10, 2019 to all shareholders of record at the close of business on April 19, 2019. About PerkinElmer ...
News, Short Squeeze, Breakout and More Instantly...
Revenue of $675 million; (30)% reported growth; (27)% organic growth; 6% non-COVID organic growth GAAP EPS of $4.50; Adjusted EPS from continuing operations of $1.01 Updates full year 2023 guidance Authorizes new $600 million share repurchase program To begin tradi...
Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Trusted partner to pharma, government and diagnostics customers with complete, end-to-end solutions To begin trading as RVTY under new name on ...
2023-05-07 19:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...